Haunted by his tragic past, Jack Carre, a heavily-scarred introvert, volunteers for a Phase I clinical trial of a miraculous new tissue regeneration medication, dubbed "Obsidian." Soon, under the watchful surveillance of respected pharmacologist, Dr.